StonvexLoading…
StonvexStonvexStonvexCore line items from NOBH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-01-31 | Annual 2025 2025-11-01 | Q3 2025 2025-08-02 | Q2 2025 2025-05-03 |
|---|---|---|---|---|
Revenue | $10.50M | $52.67M | $39.02M | $27.00M |
Operating Income | $1.83M | $10.04M | $7.21M | $5.04M |
Net Income | $1.63M | $8.45M | $6.10M | $2.29M |
EPS (Diluted) | $0.50 | $2.58 | $1.86 | $1.30 |
Total Assets | $65.95M | $67.15M | $65.65M | $65.54M |
Total Liabilities | $6.51M | $6.43M | Not available | Not available |
Cash & Equivalents | $11.08M | $13.23M | $14.36M | $13.03M |
Free Cash Flow OCF − CapEx | $1.83M | $3.98M | $3.81M | $3.13M |
Shares Outstanding | 3.15M | 3.25M | 3.27M | 3.27M |